Christine Hill-Kayser, MD
Proton beam therapy (PBT) in children and young adults with nonhematologic malignancies of the head and neck appeared to be safe and delivered local control rates similar to those seen historically.
No patient experienced adverse events (AEs) above grade 3, and no toxicity-related dose interruptions were required. The most common grade 3 AE recorded was anorexia (22%), followed by dysphagia (7%), oral mucositis, (4%) dehydration (1%), and radiation dermatitis (1%).
... to read the full story